CIK 0001991792 · Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371611499
- Phone
- (949) 409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $135,045
- in 2 filings, $135K under 10b5-1 plans
Net −$135,045. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-15 | Bellete Ambaw President and COO | Grant or award · Employee Stock Option (Right to Buy) | +284,816 | 284,816 | ||
| 2025-04-15 | Kasturi Vijay Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +203,868 | 203,868 | ||
| 2025-04-15 | Patterson Joshua F. See Remarks | Grant or award · Employee Stock Option (Right to Buy) | +119,922 | 119,922 | ||
| 2025-04-15 | Roche Corleen M. CFO | Grant or award · Employee Stock Option (Right to Buy) | +143,907 | 143,907 | ||
| 2025-03-17 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2025-03-17 | POST LEONARD E Director | Sale 10b5-1 | −1,000 | $28.00 | $28K | 0 |
| 2025-03-17 | POST LEONARD E Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,000 | 130,077 | ||
| 2025-02-18 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2025-02-18 | POST LEONARD E Director | Sale 10b5-1 | −1,000 | $28.61 | $29K | 0 |
| 2025-02-18 | POST LEONARD E Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,000 | 131,077 | ||
| 2025-01-13 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2025-01-13 | POST LEONARD E Director | Sale 10b5-1 | −1,000 | $29.66 | $30K | 0 |
| 2025-01-13 | POST LEONARD E Director | Option exercise · Director Stock Option (right to buy) 10b5-1 | −1,000 | 132,077 | ||
| 2024-12-16 | Song Hong Fang Director | Sale | −700,000 | $28.00 | $19.6M | 3,003,931 |
| 2024-12-16 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2024-12-16 | POST LEONARD E Director | Sale 10b5-1 | −1,000 | $28.84 | $29K | 0 |
| 2024-12-16 | POST LEONARD E Director | Option exercise · Stock Option 10b5-1 | −1,000 | 133,077 | ||
| 2024-12-06 | POST LEONARD E Director | Option exercise 10b5-1 | +1,000 | $0.60 | $600 | 1,000 |
| 2024-12-06 | POST LEONARD E Director | Sale 10b5-1 | −750 | $34.40 | $26K | 250 |
| 2024-12-06 | POST LEONARD E Director | Sale 10b5-1 | −250 | $34.98 | $9K | 0 |
Page 7 of 9 · 172 trades